| Financial Year |
March 31 2023 |
| Monetary Funds |
8,845,106,399.50 |
| Held-for-trading Financial Assets |
782,440,104.07 |
| Notes Receivable |
65,816,145.40 |
| Accounts Receivable |
5,766,784,617.68 |
| Advances to Suppliers |
180,722,937.97 |
| Other Receivables |
42,635,507.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,372,380,825.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
539,208,301.10 |
| Total Current Assets |
23,008,053,493.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
30,000,000.00 |
| Long-term Equity Investment |
158,758,081.11 |
| Investment Properties |
1,232,123.63 |
| Fixed Assetes |
11,004,697,160.06 |
| Under-construction Projects |
2,283,859,985.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
433,838,864.29 |
| R&D expenses |
-- |
| Goodwill |
2,408,231,666.22 |
| Long-Term Deferred and Prepaid Expenses |
523,562,077.24 |
| Deferred Income Tax Assets |
659,218,873.28 |
| Other Non-Current Assets |
1,076,579,257.97 |
| Sub-Total of Non-Current Assets |
19,897,226,880.55 |
| Total Assets |
42,905,280,374.11 |
| Short-Term Loans |
7,845,903,787.81 |
| Trading Financial liabilities |
111,542,378.20 |
| Notes Payable |
1,933,150,787.04 |
| Accounts Payable |
5,776,423,247.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
412,545,521.99 |
| Taxes Payable |
418,390,153.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,580,770.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,533,538,694.25 |
| Other Current Liabilities |
2,670,247.35 |
| Sub-Total of Current Liabilities |
18,103,356,265.27 |
| Long-term Loans |
4,674,516,625.18 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
324,019,667.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
59,762,092.71 |
| Deferred Income Tax Liabilities |
391,215,222.42 |
| Other Non-Current Liabilities |
268,750.03 |
| Sub-Total of Non-Current Liabilities |
7,972,871,334.61 |
| Total Liabilities |
26,076,227,599.88 |
| Paid-In Capital(Or Share Stock) |
1,709,867,327.00 |
| Capital Surplus |
8,058,794,634.62 |
| Surplus Reserve |
135,347,835.10 |
| LESS:Treasury Stock |
125,906,811.33 |
| Undistributed Profits |
7,749,853,188.24 |
| Minority Stockholder's Interest |
46,765,287.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,782,287,486.87 |
| Owner's Equity（Stockholder's Equity） |
16,829,052,774.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
42,905,280,374.11 |
